Demonstrate how you would apply Making Safeguarding Personal with this person at risk (500 words max).

 

What category of abuse is placing the person at most risk? Draw on the evidence in your discussion and to identify what would be the best way to intervene with this form of abuse (500 words max).

Task 3

Provide your rationale for your assessment of this person’s mental capacity. What are the implications of your decision for how you would work with the person at risk (500 words max).

Task 4

Demonstrate how you would apply Making Safeguarding Personal with this person at risk (500 words max).

Herbal Medicine: Is It More Effective Than Pharmaceuticals

Herbal Medicine: Is It More Effective Than Pharmaceuticals

How can barriers to pregnant migrant women accessing maternity services in the UK be addressed?

How can barriers to pregnant migrant women accessing maternity services in the UK be addressed?

Determine two to three (2-3) benefits of having health insurance for a family.

Health Insurance” Please respond to the following:

Determine two to three (2-3) benefits of having health insurance for a family. Specify two (2) avenues through which families may obtain health insurance.
Compare and contrast two (2) differences between health maintenance organizations (HMOs) and preferred provider organizations (PPOs). Classify the plan that you believe would be most beneficial for the majority of insured patients. Provide support for your rationale.

Health Economics” Please respond to the follwoing:

As a Human Resources manager for a mid-sized company in your area, you have been tasked with purchasing the best group health insurance for your organization. Analyze at least two (2) lifestyle choices relative to the effect(s) that these choices could have on the organization’s premiums. Support your rationale with two (2) health economic examples.
Debate It: Take a position that the full implementation of the Affordable Care Act in 2014 will or will not create a market failure for insurance companies. Provide evidence to support your position.

Is Ultrasound as accurate as Mammogram in the detection of benign breast lesions in women with dense breast?

Is Ultrasound as accurate as Mammogram in the detection of benign breast lesions in women with dense breast?

How is health information systems vital to healthcare in South Florida

-ARTICLE REVIEW
how is health information systems vital to healthcare in South Florida
– For example IT UTILIZATION
-PRIVACY/Security
-public health

PLEASE UPLOAD TGE ARTICLE WITH THE COMPLETED ASSIGNMENT, THANK YOU!

What is the benefit of inter professional care and collaboration

it has to be 500 words about the question(what is the benefit of inter professional care and collaboration) my essay is about cystic fibrosis but it has to be general but it would be good if you mentioned cystic fibrosis once and just a little sentence

i need all the pdfs of the resources sent to me too and highlight the areas from the pdf resource where you took your sentences from because i have to submit them to the professor and my team mates (preferably the resources should be from google scholar)

What is the scientific community doing to attempt to eliminate the most common forms of cancer that are ravaging society?

Individual Assignment 3 Instructions

The global community is plagued by increasing incidence of leukemia; non-Hodgkin lymphoma; lung, colorectal, breast, pancreatic, prostate, liver, ovarian, and esophageal cancers. Other types of cancer exist but are less frequent. What is the scientific community doing to attempt to eliminate the most common forms of cancer that are ravaging society?

  1. Read the course textbook’s chapter on cell division, specifically the last section on how cells become cancerous. This is context for completing Individual Assignment 3.
  2. Watch the Presentation in Module/Week 4 entitled “Ways to Fight Cancer.” Notice that the presentation outlines essentially 3 approaches to fighting cancer: a) reduction of cancer risks, b) correction of cancer genes, and c) destruction of cancerous tissue.
  3. Open the “10 Discoveries in the War on Cancer” document in the Assignment Instructions folder. Scan the discoveries briefly. Then, open the assignment submission link in Module/Week 4. In the text box, number from 1 to 10 for the 10 discoveries.
  4. Reflect carefully one discovery 1. Would this discovery be more useful for a) reducing cancer risks, b) correcting/restoring cancer cells to normal, or c) destroying cancerous tissue? After number 1 in your list, place the letter representing the approach to fighting cancer that will best be served by this new discovery. Place only 1 letter for each number. (More than 1 approach may be served, but which one is most likely to be helped most significantly?)
  5. Repeat this analysis for each of the remaining 9 discoveries. Return to the “Ways to Fight Cancer” presentation as needed for additional perspective. When finished, your entire text box must be simple: a numbered (1–10) list of letters (a), (b) or (c). The assignment is now complete.

 

 

 

 

What amount of shared savings will you have to pay back to the insurer due to your downside risk?

Referring to the Module 4 Supplemental PowerPoint (slide 24), respond to the following:

You are the director responsible for the success of your health system’s commercial ACO contracts. You’ve done a great job with quality so your focus turns to your shared savings.

You need to report back to your leadership on your two largest ACO arrangements. The financials are as follows:

Arrangement #1:

Total Attributed Population: 30,000 patients

Agreed Upon Budget: $165 Million

Percentage of Risk: 30% upside and 10% downside

Results:

Medical PMPM: $310

Pharmacy PMPM: $112

What is the shared savings amount your organization can expect?

Arrangement #2

Total Attributed Population: 45,000

Agreed Upon Budget: $230 Million

Percentage of Risk: 35% upside, 12% downside

Results:

Medical PMPM: $350

Pharmacy PMPM: $115

What amount of shared savings will you have to pay back to the insurer due to your downside risk?

Submit your response in a Word document. Include your calculations for each arrangement and explain your logic for each step.

Provide recommendations for alternative drug treatments and patient education strategies for treatment and management.

Selection of your colleagues’ responses BELOW and respond to two of your colleagues POST BELOW. Provide recommendations for alternative drug treatments and patient education strategies for treatment and management.

PEER 1 RESPONSE

Diabetes and Drug Treatments
Types of Diabetes
Diabetes type 1 can also be referred to as insulin-dependent diabetes. Initially it was referred to as juvenile-onset diabetes because, in most cases it often begun among children. Diabetes type 1 is an auto-immune disorder that causes a person’s immune system to attack and destroy cells responsible for insulin production in the pancreas (Kahanovitz, Sluss & Russell, 2017). People with type 2 diabetes can produce their own insulin but their bodies do not use the insulin very well (Wu, Ding, Tanaka & Zhang, 2014). Their bodies do not effectively use insulin as is required. Additionally, symptoms in type 1 diabetes appear more quickly compared to the type 2 symptoms, which manifest gradually. Gestational diabetes on the other hand is characterized by the temporary presence of high blood sugar, and only occurs during pregnancy. Medical specialists have attributed this kind of diabetes to hormonal changes.
Treatment for Diabetes Type 1
Diabetes Type 1 is mainly treated with insulin. People with diabetes type 1 are required to check their blood glucose regularly to make choices on the amount of food, exercise, and insulin they should take. A home glucose monitor is used to monitor the blood glucose and Insulin is administered with a syringe whenever the glucose levels are low. Patients are also encouraged to take a diet that includes carbohydrates, vegetables, legumes, low-fat milk and to stay away from sweetened beverages.
Short- and Long-Term Impacts of Type 1 Diabetics
Short term complications of type 1 diabetes include diabetic foot ulcers, hypoglycemia, hyperglycemia, peripheral artery disease and ketoacidosis. On the other hand, long term implications include heart disease, stroke, and diabetic diseases of the kidney, nerves, and the eyes. Ac According to previous research studies, prolonged use of insulin increases the risk of hypoglycemia, and mortality risk. It also exposes patients to the risk of specific cancers (Lebovitz, 2011).

References

Kahanovitz, L., Sluss, P. M., & Russell, S. J. (2017). Type 1 diabetes–a clinical perspective. Point of care, 16(1), 37.
Lebovitz, H. E. (2011). Insulin: potential negative consequences of early routine use in patients with type 2 diabetes. Diabetes Care, 34(Supplement 2), S225-S230.
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International journal of medical sciences, 11(11),1185.

PEER 2 RESPONSE
According to McCance and Huether (2019), Diabetes is the seventh leading cause of death and an estimated 30.3 million people have diabetes in 2015. Diabetes is a metabolic disease that causes a decrease of insulin either through a lack of production or resistance. Affecting many Americans today, diabetes can be associated with genetics, lifestyle habits and environmental factors. The four categories of diabetes include; Type 1 diabetes mellitus, type 2 diabetes mellitus, juvenile diabetes and gestational diabetes.

Type 1 DM- Type 1 DM is an autoimmune disease that triggers a destruction of pancreatic beta cells. These patients are often diagnosed in childhood and is usually genetically exposed to the disease. A patient diagnosed with type 1 DM cannot produce insulin, resulting in a very high and common risk for developing ketoacidosis. The treatment for these patients must include daily insulin by injection.

Type 2 DM- Diabetes type two affects 9.3% of American adults and is highest diagnosed in American Indians and Alaska Natives (McCance and Huether, 2019). DM type two is a metabolic condition that causes insulin resistance. These patients produce insulin however, due to environmental and lifestyle behaviors including obesity, these patient’s insulin become resistant to sugars requiring short term and long term glycemic control with insulin and non-insulin medications.

Juvenile DM- Juvenile diabetes occurs in persons younger than 25 years old and has an autosomal dominant inheritance. These patients are children who genetically lack beta-cell antibodies. Treatment includes non-insulin management.

Gestational Diabetes is the development of diabetes type 2 during gestation and is almost immediately resolved once the baby is born. These mothers are suggested to be screened for diabetes at the first prenatal visit to avoid misdiagnosis with type 2 DM. It is essential to educate these patients on monitoring and reducing carbohydrates and sugary foods in preventing short term and long term complications from gestational DM.

Rosenthal and Burchum (2019) recommends Metformin (Glucophage) 500mg po twice daily to treat gestational DM. A study conducted by Kampmann et al (2015), determined that gestational DM prevention and treatment techniques should include exercise, weight loss and a healthy diet before, during and after pregnancy.

Short-term effects on a patient with gestational DM includes complications for the patient and their baby. The effects of gestational DM during pregnancy according to Kampmann et al (2015), includes high risk for gestational hypertension and preeclampsia. Furthermore, the study found that 23.7% of woman with gestational DM had a direct relationship to cesarean section rate and newborns born with macrosomia.

The long-term effect of gestational DM on a woman includes a risk for developing type 2 DM later in life. Kampmann et al (2015) confirms this risk as evident by their study that concluded 40% of women with diet-modified gestational DM developed DM 10 years after pregnancy. Women should maintain a healthy weight before, during and after a pregnancy, to maintain glycemic control in-order to prevent short and long term gestational DM complications.

References
Kampmann, U. (2015). Gestational diabetes: A clinical update. World Journal of Diabetes, 6(8), 1065. https://doi.org/10.4239/wjd.v6.i8.1065
McCance, K. L., & Huether, S. E. (2014). Pathophysiology: The biologic basis for disease in adults and children. Elsevier Health Sciences.
Rosenthal, L., & Burchum, J. (2017). Lehne’s Pharmacotherapeutics for advanced practice nurses and physician assistants – E-book. Elsevier Health Sciences.